Leo Twiggs

Q: What Schools Are Affiliated With Leo Twiggs

Leo Twiggs is affiliated with the following schools: University of Minnesota, South Carolina State University, Claflin University, University of Georgia, New York University

Leo Twiggs's AcademicInfluence.com Rankings

Leo Twiggs

Computer Science

#11112

World Rank

#11739

Historical Rank

#1939

USA Rank

Database

#8140

World Rank

#8488

Historical Rank

#1057

USA Rank

computer-science Degrees

Download Badge

Computer Science

Why Is Leo Twiggs Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Leo Franklin Twiggs is an American painter and educator. He developed the Fine Art Department at South Carolina State University, where he taught from 1973 until 1998. Twiggs received his Bachelor of Arts degree from Claflin University in 1956 and his Master of Arts degree from New York University in 1964. In 1970, Twiggs became the first African American student to receive a Doctorate of Arts from the University of Georgia. He has presented over fifty one-man shows during his career.

(See a Problem?)

Leo Twiggs's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2001 Consensus Guidelines for the Management of Women with Cervical Cytological Abnormalities. (2002) (994)
2001 Consensus Guidelines for the management of women with cervical cytological abnormalities (2002) (732)
Interim Guidelines for Management of Abnormal Cervical Cytology (1994) (556)
Reproductive, menstrual, and medical risk factors for endometrial cancer: results from a case-control study. (1992) (384)
Vascular endothelial growth factor expression in early stage ovarian carcinoma (1997) (371)
Case-control study of endogenous steroid hormones and endometrial cancer. (1996) (285)
2001 Consensus guidelines for the management of women with cervical intraepithelial neoplasia. (2003) (228)
Pretreatment surgical staging of patients with cervical carcinoma (1998) (151)
Relation of endometrial cancer risk to past and contemporary body size and body fat distribution. (1993) (151)
Serum and ascitic fluid levels of interleukin‐1, interleukin‐6, and tumor necrosis factor‐alpha in patients with ovarian epithelial cancer (1993) (144)
Risk factors and hormone levels in patients with serous and endometrioid uterine carcinomas. (1997) (143)
Vascular endothelial growth factor (VEGF) expression and survival in human epithelial ovarian carcinomas. (1997) (138)
Human papillomavirus types and localization in adenocarcinoma and adenosquamous carcinoma of the uterine cervix: a study by in situ DNA hybridization. (1988) (135)
Evidence for a common etiology for endometrial carcinomas and malignant mixed mullerian tumors. (1998) (129)
Erythropoietin increases hemoglobin during radiation therapy for cervical cancer. (1994) (129)
Malignant Rhabdoid Tumor of the Vulva: Is Distinction from Epithelioid Sarcoma Possible? A Pathologic and Immunohistochemical Study (1989) (105)
Lymph node yield from laparoscopic lymphadenectomy in cervical cancer: a comparative study. (1993) (103)
Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. (2000) (94)
Malignant mixed müllerian tumor versus high-grade endometrial carcinoma and aggressive variants of endometrial carcinoma: a comparative analysis of survival. (1995) (91)
Trophoblastic pseudotumor-evidence of malignant disease potential. (1981) (87)
Dietary associations in a case-control study of endometrial cancer (1993) (85)
Mitotic count, nuclear atypia, and immunohistochemical determination of Ki-67, c-myc, p21-ras, c-erbB2, and p53 expression in granulosa cell tumors of the ovary: mitotic count and Ki-67 are indicators of poor prognosis. (1996) (84)
The revised Bethesda System for reporting cervical/vaginal cytologic diagnoses: report of the 1991 Bethesda workshop. (1992) (80)
Outcome assessment of home parenteral nutrition in patients with gynecologic malignancies: what have we learned in a decade of experience? (1993) (79)
Human genital papilloma infections: an evaluation of immunologic competence in the genital neoplasia-papilloma syndrome. (1986) (77)
Past and present physical activity and endometrial cancer risk. (1993) (76)
Flow Characteristics in Benign and Malignant Gynecologic Tumors Using Transvaginal Color Flow Doppler (1994) (74)
Prognostic significance of the presence of human papillomavirus DNA in patients with invasive carcinoma of the cervix (1989) (73)
Human papillomavirus DNA in adenocarcinoma in situ, microinvasive adenocarcinoma of the uterine cervix, and coexisting cervical squamous intraepithelial neoplasia. (1989) (72)
Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. (2010) (71)
The role of surgical debulking in cancer of the uterine cervix. (1989) (68)
Presence of human papillomavirus in verrucous carcinoma (Ackerman) of the vagina. Immunocytochemical, ultrastructural, and DNA hybridization studies. (1984) (63)
Detection of human papillomavirus DNA in invasive carcinomas of the cervix by in situ hybridization. (1987) (62)
Histological types of carcinoma of the uterine cervix and the detectability of human papillomavirus DNA. (1985) (61)
Hormonal contraception and trophoblastic sequelae after hydatidiform mole (a Gynecologic Oncology Group Study) (1989) (59)
Human ovarian epithelial cancer cells cultured in Vitro express both interleukin 1α and β genes (1992) (59)
Single‐dose actinomycin‐D treatment for nonmetastatic gestational trophoblastic disease: A prospective phase II trial of the gynecologic oncology group (1987) (58)
Small‐cell carcinoma of the endometrium: Light microscopic and ultrastructural study of a case (1982) (57)
A Prospective Randomized Comparison of Methotrexate, Dactinomycin, and Chlorambucil Versus Methotrexate, Dactinomycin, Cyclophosphamide, Doxorubicin, Melphalan, Hydroxyurea, and Vincristine in “Poor Prognosis” Metastatic Gestational Trophoblastic Disease: A Gynecologic Oncology Group Study (1989) (55)
Role of whole abdominal radiation therapy in the management of endometrial cancer; prognostic importance of factors indicating peritoneal metastases. (1985) (55)
Oral contraceptive use and risk of gestational trophoblastic tumors. (1999) (54)
Invasive vulvar tumors in young women--a disease of the immunosuppressed? (1993) (52)
Spectroscopic Imaging as a Triage Test for Cervical Disease: A Prospective Multicenter Clinical Trial (2006) (50)
Acute pulmonary complications of molar pregnancy. (1979) (50)
Phase I trial of taxol as a radiation sensitizer with cisplatin in advanced cervical cancer. (1997) (50)
Oral contraceptives and endometrial cancer: Do other risk factors modify the association? (1993) (49)
Moderate alcohol consumption and the risk of endometrial cancer. (1993) (49)
The effect of sartorius transposition on wound morbidity following inguinal-femoral lymphadenectomy. (1997) (47)
Association of Ki-ras with amplified DNA sequences, detected in human ovarian carcinomas by a modified in-gel renaturation assay. (1989) (47)
Pelvic adhesion formation after pelvic lymphadenectomy: comparison between transperitoneal laparoscopy and extraperitoneal laparotomy in a porcine model. (1994) (46)
Early invasive and in situ warty carcinoma of the vulva: clinical, histologic, and electron microscopic study with particular reference to viral association. (1982) (46)
Rectus abdominis myocutaneous flap for primary vaginal reconstruction. (1993) (46)
The morbidity and utility of periaortic radiotherapy in cervical carcinoma. (1983) (45)
Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. (2004) (45)
Blood flow characteristics of ovarian tumors: implications for ovarian cancer screening. (1995) (42)
Circadian-timed Combination Doxorubicin-cisplatin Chemotherapy for Advanced Endometrial Carcinoma: A Phase Ii Study of the Gynecologic Oncology Group (1993) (42)
Cytoplasmic estrogen and progesterone receptors in primary cervical carcinoma: clinical and histopathologic correlates. (1983) (41)
Primary malignant melanoma of the vagina: a clinicopathological analysis of 10 cases. (1990) (40)
Therapeutic implications of the natural history of advanced cervical cancer as defined by pretreatment surgical staging (1985) (40)
Human Papillomavirus DNA in Adenosquamous Carcinoma and Squamous Cell Carcinoma of the Vulva (1988) (38)
Endometrial cancer risk in relation to serum lipids and lipoprotein levels. (1994) (37)
Cigarette smoking and the risk of endometrial cancer. (1993) (37)
Sensitivity of koilocytosis, immunocytochemistry, and electron microscopy as compared to DNA hybridization in detecting human papillomavirus in cervical and vaginal condyloma and intraepithelial neoplasia. (1986) (37)
Prognostic importance of progesterone and estrogen receptors in cancer of the uterine cervix (1986) (37)
Gynecologic reconstruction with a rectus abdominis myocutaneous flap: an update. (1996) (35)
α‐1 acid glycoprotein is an immunosuppressive factor found in ascites from ovarian carcinoma (1997) (35)
Vulvar melanoma: a microstaging study. (1982) (33)
Logistic models for prediction of enteric morbidity in the treatment of ovarian and cervical cancers. (1983) (32)
Intrauterine device use and endometrial cancer risk. (1997) (29)
Mixed intestinal adenocarcinoma-argentaffin carcinoma of the vagina. (1986) (29)
Condylomatous Carcinoma of the Vulva With Special Reference to Human Papillomavirus DNA (1988) (29)
The implementation of critical pathways in gynecologic oncology in a managed care setting: a cost analysis. (2001) (28)
Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease (1986) (28)
Carcinoma of the cervix, FIGO Stage IB: treatment failures. (1984) (26)
Effect of cis‐Platinum on Tolerance to Radiation Therapy in Advanced Cervical Cancer (1986) (26)
The impact of extraperitoneal surgical staging on morbidity and tumor recurrence following radiotherapy for cervical carcinoma (1984) (25)
Carcinoma of the uterine cervix FIGO Stage I-B. (1982) (25)
Metastatic placental site trophoblastic tumor (1998) (25)
Vaginal recurrence of adenocarcinoma of the endometrium. (1980) (25)
Transvaginal sonography as an aid in the clinical staging of carcinoma of the cervix (1992) (25)
Histogenesis of cervical adenocarcinoma with reference to human papillomavirus-18 as a carcinogen. (1989) (24)
Management of pelvic venous stenosis with intravascular stainless steel stents. (1995) (24)
Pulse actinomycin D scheduling in nonmetastatic gestational trophoblastic neoplasia: cost-effective chemotherapy. (1983) (23)
Pretreatment extraperitoneal surgical staging in primary carcinoma of the cervix uteri. (1984) (23)
How accurate is the pelvic examination as compared to transvaginal sonography? A prospective, comparative study. (1994) (22)
A novel strategy using G-CSF to support EMA/CO for high-risk gestational trophoblastic disease. (1995) (22)
The Analysis of Carcinomas of the Vagina for Human Papillomavirus DNA (1988) (21)
Alpha-1 acid glycoprotein is an immunosuppressive factor found in ascites from ovaria carcinoma. (1997) (20)
On the lack of demonstrated clinical benefit of neoadjuvant cisplatinum therapy for cervical cancer. (1993) (20)
Treatment of vaginal intraepithelial neoplasia with the CO2 laser. (1985) (19)
Multicenter Direct to Vial Evaluation of a Liquid-Based Pap Test (2004) (19)
Ascites levels of haptoglobin in patients with ovarian cancer (1993) (19)
Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol. (1994) (19)
Human ovarian epithelial cancer cells cultures in vitro express both interleukin 1 alpha and beta genes. (1992) (18)
Signet Ring Cell Lobular Carcinoma of the Breast Presenting in a Cervicovaginal Smear (2000) (18)
Concurrent weekly cis-platinum and radiotherapy in advanced cervical cancer: a preliminary dose escalating toxicity study. (1986) (18)
Tubal sterilization and risk of cancer of the endometrium. (2000) (17)
Analysis of histopathological features of endometrioid uterine carcinomas and epidemiologic risk factors. (1998) (17)
Prognostic significance of steroid receptors measured in primary metastatic and recurrent endometrial carcinoma. (1989) (16)
Resolution of pulmonary metastases with chemotherapy in a patient with placental site trophoblastic tumor (1992) (16)
Tolerance and preliminary results of simultaneous therapy with radiation and cisplatin for advanced cervical cancer. (1988) (16)
Twenty-five year outcome of sequential abdominal radiotherapy and melphalan:implications for future management of epithelial carcinoma of the ovary. (2005) (15)
Cytosolic estrogen and progesterone receptors as prognostic parameters in stage IB cervical carcinoma. (1987) (15)
Multimodality therapy for advanced and recurrent vulvar squamous cell carcinoma. A pilot project. (1990) (15)
Basal cell pseudopodia in cervical intraepithelial neoplasia; progressive reduction of number with severity: a morphometric quantification. (1981) (14)
Nonsurgical management strategies for the functional complications of ileocolonic continent urinary reservoirs. (1995) (14)
Gonadal tumors in patients with gonadal dysgenesis and sex chromosomal rings and fragments. (1984) (14)
Multimodal hyperspectroscopy as a triage test for cervical neoplasia: pivotal clinical trial results. (2013) (14)
Metastatic gestational trophoblastic neoplasia complicated by tumor lysis syndrome, heart failure, and thyrotoxicosis: a case report. (2010) (13)
Erosion of an intraperitoneal chemotherapy catheter resulting in an enterovaginal fistula. (2000) (13)
Decision theory analysis of the enteric morbidity and surgical staging in the treatment of advanced cervical cancer. (1984) (13)
Nonneoplastic Complications of Molar Pregnancy (1984) (13)
The utility and limitations of decision theory in the utilization of surgical staging and extended field radiotherapy in cervical cancer. (1984) (13)
Resection of the Pubic Bone as an Adjunct to Management of Primary, Recurrent, and Metastatic Pelvic Malignancies (1989) (12)
Symptomatic central venous thrombosis and long-term right atrial catheters. (1990) (12)
2001 Consensus Guidelines for the Management of Women with Cervical Intraepithelial Neoplasia (2003) (12)
Pseudomyxoma Peritonei ‐ Experience from a Tertiary Referral Centre (1991) (11)
Managing abnormal cytology results in pregnancy. (2005) (11)
A Phase I Study using low-dose fractionated whole abdominal radiotherapy as a chemopotentiator to full-dose cisplatin for optimally debulked stage III/IV carcinoma of the endometrium. (2011) (11)
The interplay of local and distant control in the cure of cervical cancer (1990) (11)
Measurement of number and cross-sectional area of basal cell pseudopodia: a new morphometric method (1981) (10)
Immunocytochemical evidence of heterogenous origin of α-fetoprotein in immature teratoma of the ovary (1985) (10)
Transforming Growth Factor-Alpha Levels in the Serum and Ascites of Patients withAdv anced Epithelial Ovarian Cancer (1999) (10)
ICRF‐159 (Razoxane) in Patients with Advanced Adenocarcinoma of the Endometrium A Gynecologic Oncology Group Study (1986) (9)
Colposcopy: Management options (2003) (8)
The Costs of Carcinoma of the Cervix (1972) (8)
High-grade squamous intraepithelial lesions. (2003) (8)
The utility of preoperative screening colonoscopy in gynecologic oncology. (1995) (8)
A prospective randomized comparison of methotrexate, Actinomycin-D, and chlorambucil (MAC) versus modified Bagshawe regimen in “poor-prognosis” gestational trophoblastic disease (1987) (8)
High-Risk HPV DNA Testing and HPV-16/18 Genotyping: What Is the Clinical Application? (2011) (6)
Automated Primary Screening Devices (2000) (6)
Serum levels of macrophage colony-stimulating factor in patients with ovarian cancer undergoing second-look laparotomy. (1992) (6)
Searching for an efficient institutional review board review model: Interrelationship of trainee-investigators, funding, and initial approval. (2005) (6)
Placental site trophoblastic tumor presenting with scalp metastases (1995) (5)
Preliminary report of toxicity in a randomized comparison of methotrexate, actinomycin D, and chlorambucil (MAC) versus modified Bagshawe regimen in “poor prognosis” gestational trophoblastic disease (1985) (5)
Infectious Morbidity After Radical Vulvectomy (1994) (4)
93154903 Oral contraceptives and endometrial cancer: do other risk factors modify the association? (1994) (4)
Concomitant whole‐abdominal radiation and intraperitoneal chemotherapy in advanced ovarian carcinoma. A pilot study (1991) (4)
Recurrent squamous cell carcinoma in a rectus abdominis neovagina. (1995) (4)
Evidence Supporting the Current Management Guidelines for High-Grade Squamous Intraepithelial Lesion Cytology (2004) (4)
Major basic protein as a marker of malignant potential in trophoblastic neoplasia. (1996) (4)
Surgical intervention following multimodality therapy for advanced cervical cancer. (1990) (4)
Hormone Replacement Therapy in Endometrial Cancer Survivors: New Perspectives After the Heart and Estrogen Progestin Replacement Study and the Women's Health Initiative (2006) (3)
Transvaginal ultrasound in gynecologic oncology. (1991) (3)
The Integration of Whole Abdominal Radiotherapy and Intraperitoneal Cisplatin into the Primary Management of Advanced Ovarian Carcinoma (1991) (3)
A sea change in diagnosing and managing HPV and cervical disease-Part II (2002) (3)
Human Papillomavirus Vaccination: The Policy Debate Over the Prevention of Cervical Cancer-A Commentary (2008) (3)
Quality of Life Assessment in Gynaecological Cancer Patients (1995) (3)
Laparoendoscopic single-site extraperitoneal aortic lymphadenectomy: first experience. (2011) (3)
Cross-protection from human papillomavirus 16/18 against types 45 and 31: fact or fancy? (2008) (3)
Immunocytochemical evidence of heterogeneous origin of alpha-fetoprotein in immature teratoma of the ovary. (1985) (3)
A Manual of Clinical Colposcopy (1999) (2)
A simplified method for detubularization in the construction of a continent ileocolic reservoir (Miami pouch). (1997) (2)
Documentation of subclinical trophoblastic embolization with invasive cardiac monitoring in a woman with a molar pregnancy. A case report. (1986) (2)
Gravlee jet irrigator. Efficacy in diagnosis of endometrial neoplasia. (1976) (2)
Association of Human Papillomavirus with Vulvar and Vaginal Intraepithelial Disease: Opportunities for Prevention (2008) (2)
Marker rhythmometry with macrophage-colony stimulating factor (M-CSF). (1991) (2)
How do you evaluate an atypical glandular cell papanicolaou smear with psammoma bodies present? (1997) (2)
Single agent weekly methotrexate (MTX) therapy in the treatment of nonmetastatic gestational trophoblastic disease (NMGTD) (1987) (2)
Basal cell pseudopodia and the degree of maturation of squamous metaplasia of the uterine cervix: a morphometric quantification. (1983) (2)
Surgical intervention following multimodality therapy for advanced cervical cancer (1991) (2)
Treatment of advanced ovarian carcinoma with high-dose cyclophosphamide after falure on melphalan. (1977) (2)
A Manual of Clinical Laparoscopy (1999) (1)
The impact of nodal involvement and recurrence status on operative morbidity of pretreatment surgical staging in cervical carcinoma (1990) (1)
The place of colposcopy and related systems in gynecological practice and research. (1989) (1)
A Comparison of Vascular Pulsatility and Resistive Indices in Gynecological Tumor Detection Using Transvaginal Ultrasound (1995) (1)
Gravlee Jet Irrigator as a Screening Method?-Reply (1976) (1)
Is colposcopy and/or biopsy always necessary? (2013) (1)
Management of complications of laparoscopic surgery in gynaecology (1993) (1)
Teniposide in epithelial ovarian carcinoma: a phase II trial of the Gynecologic Oncology Group. (1986) (1)
Translocation of microbial organisms to pelvic lymph nodes as a possible cause of postoperative infection in gynecologic oncology patients (1992) (1)
Unilateral twin interstitial ectopic pregnancy. Report of a case. (1977) (1)
A Decision Theory Analysis of Radiotherapeutic and Chemotherapeutic Toxicity in the Management of Ovarian Cancer (1986) (1)
Analysis of Histopathological Features of Endometrioid Uterine (2012) (1)
Placental protein 5 in gestational trophoblastic disease: localization and circulating levels. (1982) (1)
Metastatic placental site trophoblastic tumor. (1998) (1)
Acute pulmonary complications of molar pregnancy (1980) (1)
Safety and efficacy of pegfilgrastim administration on the same day as myelosuppressive chemotherapy (CT) in women with ovarian or primary peritoneal cancer (2007) (0)
The utility of preoperative screening colonoscopy in gynecologic oncology (1995) (0)
Transvaginal color flow Doppler and the detection of pelvic malignancies (1992) (0)
Use of positron emission tomography (PET) scan versus surgical staging in the pre-treatment evaluation of locally advanced cervical carcinoma: A cost effectiveness analysis (2012) (0)
Levels of macrophage colony-stimulating factor (M-CSF), interleukin-1 (IL-1), interleukin-6 (IL-6) and TNF alpha in human ovarian cancer (1991) (0)
Clinical question: ask the expert. (2007) (0)
A 23-year-old woman has her first Pap smear, thin prep smear interpreted as "high grade squamous intraepithelial lesion". (2008) (0)
An Analysis of Adjuvant Treatment Strategies for Carcinoma of the Cervix (1989) (0)
Enumeration of the number of microprocesses of cultured murine T-lymphoma cells: A comparative study of two new morphometric methods (1983) (0)
Concomitant whole abdominal radiation and intraperitoneal cisplatin chemotherapy in advanced ovarian carcinoma: A pilot study (1990) (0)
Past and present physical activity and endometrial cancer risk.: 11 (1994) (0)
A 14-Year-Old Female With LSIL. (2002) (0)
Clinical question: ask the experts. (2004) (0)
Cytosolic estrogen and progesterone receptors in primary cervical carcinoma (1987) (0)
Spectroscopie lmaging as a Triage Test for Cervical Disease : A Prospective Multicenter Clinical Trial (2014) (0)
A pilot study of alternating courses of cisplatin/cyclophosphamide and carboplatin/etoposide in advanced ovarian cancer (1994) (0)
00024 RADICAL ABDOMINAL HYSTERECTOMY FOR INVASIVE CERVICAL CANCER AT THE UNIVERSITY OF MIAMI: A LOOK AT OUR 40-YEAR EXPERIENCE (2005) (0)
Editorial: Identifying gaps in the knowledge base underlying cervical cytology guidelines (2002) (0)
Outcome assessment of home parenteral nutrition in gynecologic malignancies: The University of Minnesota experience (1991) (0)
EPIDEMIOLOGY Volume 137 (1993) (0)
Human papillomavirus infection of the cervix in a 14-year-old girl. (2003) (0)
Pastandpresent physical activity andendometrial cancerrisk (1993) (0)
How should a patient with a series of abnormal pap smears be managed? (2001) (0)
Urinary tract infection in women with gynecologic malignancy (1992) (0)
Home study course: spring 2004. (2004) (0)
Cardiac metastasis of cloacagenic carcinoma of the vagina: a case and review of gynecologic malignancies with cardiac metastasis. (2000) (0)
Significance of pregnancy-associated major basic protein (pMBP) in trophoblastic disease (1992) (0)
Paracrine loop of immune suppression in ovarian cancer (1992) (0)
Detection of Human Papillomavirus DNA in Invasive Carcinomas of the Cervix by in Situ Hybridization 1 (2006) (0)
The rationalization for infrequent Pap smears. (1982) (0)
Serum levels of macrophage colony‐stimulating factor in patients with ovarian cancer undergoing second‐look laparotomy (1992) (0)
Pre- and postevacuation hemodynamic and metabolic studies of hydatidiform mole and severe pregnancy-induced hypertension. A case report. (1980) (0)
Clinical correlations in preinvasive and early invasive vulvar neoplasia: A subset of genital neoplasia papilloma syndrome (GENPS) (1984) (0)
Urinary diversion in pelvic exenteration: The role of conduit choice in postoperative morbidity (1991) (0)
Morphometric Analysis of Basal Cell-Stroma Interface in Normal and Abnormal Cervical Epithelium (1982) (0)
Genital Neoplasia-Papilloma Syndrome: A Unifying Concept of Human Genital Papillomavirus Infection and Expression (1986) (0)
76 Twenty-five year outcome of sequential abdominopelvic radiotherapy and alkylating agent chemotherapy for ovarian carcinoma (1997) (0)
Takashi Okagaki, M.D., Ph.D., M.P.H. (1933-2010) (2011) (0)
Development of two new monoclonal antibodies reactive to a unique antigenic determinant present on human ovarian cancer cells (1992) (0)
100 Interactive Basic and Advanced Case-Studies (2001) (0)

This paper list is powered by the following services:

Other Resources About Leo Twiggs

en.wikipedia.org

What Schools Are Affiliated With Leo Twiggs?

Leo Twiggs is affiliated with the following schools: